Macedonia's drug maker Alkaloid boosts sales by 14.7% y/y in Jan-Sep 2011.

By bne IntelliNews November 1, 2011
The sales revenues of Macedonia's largest pharmaceuticals producer Alkaloid have increased by 14.7% y/y to MKD 4.95bn (EUR 80.4mn) in January-September, according to the consolidated income statement published on the website of the Macedonian Stock Exchange. Exports accounted for 58.8% of sales. The company's operating profit rose by 2.7% y/y to MKD 511mn, and the bottom line added 2.6% y/y to MKD 437.8mn.

Related Articles

Macedonias 2013 tobacco crop expected to exceed 30,000 tonnes.

Macedonias tobacco crop is expected to increase by 20% to over 30,000 tonnes in 2013, Utrinski vesnik daily reported quoting Danco Mileski, president of the countrys tobacco association. The ... more

Macedonia cancels tender for gas distribution network feasibility study.

The transport ministry has cancelled the tender for preparing a feasibility study for developing the countrys natural gas distribution network, build.mk portal reported. Reportedly, two bids were ... more

Komercijalna Banka wins Global Finance award Best Bank in Macedonia for 2013.

Large-sized commercial bank Komercijalna Banka announced that it has won the award Best Bank in Macedonia for 2013 by the magazine Global Finance. The Macedonian bank wins the award for a 10th ... more

Notice: Undefined index: subject_id in /var/www/html/application/controllers/IndexController.php on line 335
Dismiss